These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Risk modelling the mortality impact of antimicrobial resistance in secondary pneumococcal pneumonia infections during the 2009 influenza pandemic. Barnes CE; MacIntyre CR Int J Infect Dis; 2019 Aug; 85():1-6. PubMed ID: 31096052 [TBL] [Abstract][Full Text] [Related]
3. Pneumococcal pneumonia and influenza: a deadly combination. Klugman KP; Chien YW; Madhi SA Vaccine; 2009 Aug; 27 Suppl 3():C9-C14. PubMed ID: 19683658 [TBL] [Abstract][Full Text] [Related]
4. Major issues and challenges of influenza pandemic preparedness in developing countries. Oshitani H; Kamigaki T; Suzuki A Emerg Infect Dis; 2008 Jun; 14(6):875-80. PubMed ID: 18507896 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of stockpiling 23-valent pneumococcal polysaccharide vaccine to prevent secondary pneumococcal infections among a high-risk population in the United States during an influenza pandemic. Dhankhar P; Grabenstein JD; O'Brien MA; Dasbach EJ Clin Ther; 2010 Aug; 32(8):1501-16. PubMed ID: 20728763 [TBL] [Abstract][Full Text] [Related]
6. The anticipated severity of a "1918-like" influenza pandemic in contemporary populations: the contribution of antibacterial interventions. Chien YW; Levin BR; Klugman KP PLoS One; 2012; 7(1):e29219. PubMed ID: 22291887 [TBL] [Abstract][Full Text] [Related]
7. It's the wheezin' season. A nasty influenza strain hits the U.S. Tangley L US News World Rep; 2000 Jan; 128(2):49. PubMed ID: 11184570 [No Abstract] [Full Text] [Related]
8. Vaccines and antiviral drugs in pandemic preparedness. Monto AS Emerg Infect Dis; 2006 Jan; 12(1):55-60. PubMed ID: 16494718 [TBL] [Abstract][Full Text] [Related]
10. Bacterial pneumonia as an influenza complication. Martin-Loeches I; van Someren Gréve F; Schultz MJ Curr Opin Infect Dis; 2017 Apr; 30(2):201-207. PubMed ID: 27984245 [TBL] [Abstract][Full Text] [Related]
11. [Various sides of influenza. Part II--epidemiology, influenza surveillance and prophylaxis]. Machała MK; Brydak LB Pol Merkur Lekarski; 2006 Sep; 21(123):277-85. PubMed ID: 17163191 [TBL] [Abstract][Full Text] [Related]
12. Influenza pandemic: preparedness planning in Germany. Fock R; Bergmann H; Bussmann H; Fell G; Finke EJ; Koch U; Niedrig M; Peters M; Riedmann K; Scholz D; Wirtz A Euro Surveill; 2002 Jan; 7(1):1-5. PubMed ID: 12631952 [TBL] [Abstract][Full Text] [Related]
13. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. Morens DM; Taubenberger JK; Fauci AS J Infect Dis; 2008 Oct; 198(7):962-70. PubMed ID: 18710327 [TBL] [Abstract][Full Text] [Related]
15. Planning for the next pandemic of influenza. Gust ID; Hampson AW; Lavanchy D Rev Med Virol; 2001; 11(1):59-70. PubMed ID: 11241802 [TBL] [Abstract][Full Text] [Related]
17. [Respiratory tract infections in the elderly living in institutions: prevention]. Chassagne P; Bentot-Levasseur C; Druesne L; Bercoff E; Doucet J Rev Mal Respir; 2002 Oct; 19(5 Pt 1):627-32. PubMed ID: 12473949 [TBL] [Abstract][Full Text] [Related]
18. Pandemic influenza and healthcare demand in the Netherlands: scenario analysis. van Genugten ML; Heijnen ML; Jager JC Emerg Infect Dis; 2003 May; 9(5):531-8. PubMed ID: 12737735 [TBL] [Abstract][Full Text] [Related]
19. Acute respiratory infections: the forgotten pandemic. Communiqué from the International Conference on Acute Respiratory Infections, held in Canberra, Australia, 7-10 July 1997. Int J Tuberc Lung Dis; 1998 Jan; 2(1):2-4. PubMed ID: 9562104 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of whole-cell killed bacterial vaccines in preventing pneumonia and death during the 1918 influenza pandemic. Chien YW; Klugman KP; Morens DM J Infect Dis; 2010 Dec; 202(11):1639-48. PubMed ID: 21028954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]